Investing.com - Financial Markets Worldwide

American Healthcare REIT stock hits all-time high at 41.51 USD

Published 20/08/2025, 16:10
American Healthcare REIT stock hits all-time high at 41.51 USD
AHR
0.07%

American Healthcare REIT Inc. stock reached a significant milestone, hitting an all-time high of 41.51 USD. With a market capitalization of $6.9 billion and a healthy current ratio of 1.61, this marks a notable achievement for the company, reflecting a robust performance over the past year. InvestingPro analysis suggests the stock is currently trading above its Fair Value. Over the last 12 months, the stock has experienced a remarkable 109.32% increase, showcasing strong investor confidence and a positive market trajectory. The company maintains a 2.45% dividend yield and achieved 10.05% revenue growth, with analyst price targets ranging from $37 to $50. This surge in stock price highlights the company’s ability to navigate market challenges and capitalize on growth opportunities, positioning itself as a formidable player in the healthcare real estate investment sector. InvestingPro subscribers can access 12 additional exclusive tips and a comprehensive Pro Research Report for deeper insights.

In other recent news, American Healthcare REIT has reported strong second-quarter 2025 financial results, with a notable 27% increase in normalized funds from operations (NFFO) per share. The company also raised its full-year 2025 NFFO guidance, indicating a positive outlook for the remainder of the year. Following these results, several analyst firms have adjusted their price targets for the company. Truist Securities increased its price target to $44, citing the company’s robust earnings and favorable industry positioning. Similarly, RBC Capital raised its target to $45, describing the earnings as "solid." JMP Securities also adjusted its target to $45, noting that the company’s Core FFO of $0.42 per share exceeded their expectations. These developments reflect a strong performance by American Healthcare REIT and positive sentiment from analysts regarding its future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.